Paul Peter Tak - Feb 12, 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Executive Officer, Director
Signature
/s/ Charles Schoch, as Attorney-in-Fact for Paul Peter Tak
Stock symbol
CADL
Transactions as of
Feb 12, 2025
Transactions value $
$0
Form type
4
Date filed
2/14/2025, 04:30 PM
Previous filing
Jan 17, 2025
Next filing
Mar 20, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +525K $0.00 525K Feb 12, 2025 Common Stock 525K $8.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following February 12, 2025, subject to the Reporting Person's continued service on each vesting date.

Remarks:

Exhibit 24 - Power of Attorney. This Power of Attorney was inadvertently omitted from the Form 4 filed on July 15, 2024.